HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)

A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
Also Known As:
MPTP; N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-
Networked: 3976 relevant articles (235 outcomes, 593 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jenner, Peter: 38 articles (04/2018 - 02/2002)
2. Di Paolo, Thérèse: 37 articles (12/2021 - 01/2002)
3. Bezard, Erwan: 36 articles (12/2020 - 11/2003)
4. Huot, Philippe: 33 articles (08/2022 - 01/2010)
5. Brotchie, Jonathan M: 32 articles (01/2019 - 08/2003)
6. Fox, Susan H: 28 articles (01/2022 - 11/2002)
7. Morissette, Marc: 26 articles (12/2021 - 01/2002)
8. Grégoire, Laurent: 23 articles (01/2018 - 12/2003)
9. Jackson, Michael J: 22 articles (04/2018 - 09/2002)
10. Li, Qin: 21 articles (12/2020 - 07/2005)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Parkinsonian Disorders (Parkinsonism)
3. Dyskinesias (Dyskinesia)
4. Neuroinflammatory Diseases
5. Mitochondrial Diseases (Mitochondrial Disease)

Related Drugs and Biologics

1. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
2. Dopamine (Intropin)
3. Levodopa (L Dopa)
4. Proteins (Proteins, Gene)
5. Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
6. Cyclosporine (Ciclosporin)
7. Neurotoxins
8. 1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)
9. Synucleins
10. Probenecid (Benemid)

Related Therapies and Procedures

1. Therapeutics
2. Aftercare (After-Treatment)
3. Resuscitation
4. Injections
5. Intranasal Administration